China Resources Sanjiu Medical & Pharmaceutical Co 000999.SZ · CNY
Health Care · Shenzhen · 🇨🇳 China
25.69
-1.00%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About China Resources Sanjiu Medical & Pharmaceutical Co
Its shares trade on Shenzhen under the ticker 000999.SZ. It has been listed since 9 March 2000. In the fiscal year to 31 December 2025, it reported revenue of CN¥31.60bn and net income of CN¥3.42bn. At that date it held total assets of CN¥58.80bn and shareholders' equity of CN¥22.17bn.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the manufacture, development, and sale of pharmaceutical products. The company is headquartered in Shenzhen, Guangdong. The company went IPO on 2000-03-09. The firm's pharmaceutical products include over the counter (OTC) drugs and prescription drugs. The firm's drugs are used for the treatment in cold, gastroenterology, dermatology, pediatrics, cardiovascular and cerebrovascular diseases, anti-tumor, anti-infection, digestive system, orthopedics and other areas. The firm is also involved in packaging and printing and international trading businesses. The firm distributes its products in domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 9 Mar 2000
- Employees
- 15,599
- Website
- 999.com.cn ↗
Leadership
Pay as last reported
- Mr. Huawei QiuChairman of the Board, since 2007CN¥2.9m
- Mr. Wenduo WuPresident, DirectorCN¥900,000
- Mr. Jian XingChief Financial Officer, Secretary of the Board
- Ms. Hui ZhouChief Compliance Officer, Vice President, General Counsel, Director, since 2001CN¥2.6m
- Mr. Xianfeng HuangVice PresidentCN¥192,400
- Mr. Yi MaiVice PresidentCN¥2.6m
- Mr. Ke WangVice PresidentCN¥137,700
- Mr. Liang WangVice PresidentCN¥2.4m
- Mr. Xiaosong BaiDirectorCN¥1.1m
- Mr. Xingpin CuiDirector
- Mr. Zhuqiang LiangDirector
- Mr. Shutian YuDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 89
- Environment
- 99
- Social
- 99
- Governance
- 69
- Direct emissions (scope 1)
- 55,312.19 t
- Energy emissions (scope 2)
- 166,808.46 t
- Women in the workforce
- 46.41805%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- China Resources Sanjiu Medical & Pharmaceutical Co Ltd employs 15,599 full-time staff members in Shenzhen.
- The company manufactures over the counter drugs and prescription drugs for diverse medical conditions.
- Pharmaceutical products treat cold, gastroenterology, dermatology, pediatrics, cardiovascular, and cerebrovascular diseases effectively.
Weaknesses
- The firm relies on domestic market distribution for its pharmaceutical products and services.
- Packaging and printing businesses may not generate sufficient revenue compared to core drug sales.
- International trading operations face potential logistical challenges in overseas markets without clear advantages.
Opportunities
- Expanding international trading businesses could increase revenue from overseas markets significantly.
- Developing new anti-tumor and anti-infection drugs addresses growing global health care needs.
- Leveraging 15,599 employees to enhance production capacity for cardiovascular disease treatments.
Threats
- Competition in the pharmaceutical sector may reduce market share for existing products.
- Regulatory changes in overseas markets could hinder international trading business operations.
- Economic fluctuations might decrease consumer spending on over the counter drugs.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.